Certain A Shares of Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 25-JAN-2024. These A Shares will be under lockup for 1100 days starting from 20-JAN-2021 to 25-JAN-2024.

Details:
Li Yanfei, the controlling shareholder, actual controller and chairman of the board of directors, and their concerted actions persons, directors Zhou Yuewu and Li Jin, consistent action person controlled by the actual controller, Hesen Investment Co., Ltd and Heqi Investment Co., Ltd committed that within 36 months since the date of listing of the present shares, there will not be no transfers nor entrustment of shares to any third party nor repurchase by the Company. If, within 6 months after the issuer's listing, the closing price of the shares is lower than issuance price for 20 consecutive trading days or if trading price is lower than issuance price after 6 month from listing, lock-up period will be automatically extended for another 6 months. After the expiry of the lock-up period (including the extended lock-up period), the parties promise that yearly transfer of shares made by them will not exceed 25% of the holding, both direct and indirect, held by the present parties.

Tian Wenshu, supervisor of the company, Zhan Deyan, Hao Ruizhi and Lei Qigang, directors and managing personnel of the company, shareholder Chengdu Technology Transfer Venture Co., Ltd, Other shareholders of the company Hairong No.6 Investment, Hairong No.1 Investment, Shenzhen Dingfeng Investment, Boyuan Xinhang Venture Capital, Sichuan Hai Te Venture Capital, and Boyuan Tianhong Investment co., Ltd committed that within 12 months since the date of listing of the present shares, there will be no transfers nor entrustment of shares to any third party nor repurchase by the company.